These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21122681)

  • 1. Activation of intracellular signaling systems by high-density lipoproteins.
    Toth PP
    J Clin Lipidol; 2010; 4(5):376-81. PubMed ID: 21122681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin.
    Rodríguez C; González-Díez M; Badimon L; Martínez-González J
    Thromb Haemost; 2009 Apr; 101(4):665-73. PubMed ID: 19350109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.
    Kimura T; Sato K; Malchinkhuu E; Tomura H; Tamama K; Kuwabara A; Murakami M; Okajima F
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1283-8. PubMed ID: 12775579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
    González-Díez M; Rodríguez C; Badimon L; Martínez-González J
    Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiatherogenic and antiinflammatory effect of HDL-associated lysosphingolipids operates via Akt -->NF-kappaB signalling pathways in human vascular endothelial cells.
    Schmidt A; Geigenmüller S; Völker W; Buddecke E
    Basic Res Cardiol; 2006 Mar; 101(2):109-16. PubMed ID: 16450077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoproteins: marker of cardiovascular risk and therapeutic target.
    Toth PP; Davidson MH
    J Clin Lipidol; 2010; 4(5):359-64. PubMed ID: 21122679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
    Kimura T; Okajima F; Murakami M
    Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling by the high-affinity HDL receptor scavenger receptor B type I.
    Saddar S; Mineo C; Shaul PW
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):144-50. PubMed ID: 20089950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
    Marcil M; O'Connell B; Krimbou L; Genest J
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine 1-phosphate receptors mediate the lipid-induced cAMP accumulation through cyclooxygenase-2/prostaglandin I2 pathway in human coronary artery smooth muscle cells.
    Damirin A; Tomura H; Komachi M; Tobo M; Sato K; Mogi C; Nochi H; Tamoto K; Okajima F
    Mol Pharmacol; 2005 Apr; 67(4):1177-85. PubMed ID: 15625281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.
    Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F
    Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells.
    Negre-Salvayre A; Dousset N; Ferretti G; Bacchetti T; Curatola G; Salvayre R
    Free Radic Biol Med; 2006 Oct; 41(7):1031-40. PubMed ID: 16962927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.
    Bühler FR; Tkachuk VA; Hahn AW; Resink TJ
    J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis.
    Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
    Frias MA; James RW; Gerber-Wicht C; Lang U
    Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
    Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
    Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
    Potì F; Simoni M; Nofer JR
    Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins.
    Tölle M; Schuchardt M; van der Giet M
    Curr Pharm Des; 2010 May; 16(13):1468-79. PubMed ID: 20196741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.